Vitamin Blue, Inc.
VTMB · OTC
12/31/2017 | 12/31/2016 | 12/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Revenue | $250 | $217 | $130 | $105 |
| % Growth | 15.1% | 67.5% | 23.5% | – |
| Cost of Goods Sold | $154 | $130 | $74 | $73 |
| Gross Profit | $97 | $87 | $55 | $32 |
| % Margin | 38.6% | 40.2% | 42.8% | 30.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $131 | $119 | $174 | $160 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $131 | $119 | $175 | $160 |
| Operating Income | -$34 | -$32 | -$119 | -$128 |
| % Margin | -13.7% | -14.8% | -91.9% | -122% |
| Other Income/Exp. Net | $13 | -$56 | $12 | -$96 |
| Pre-Tax Income | -$21 | -$88 | -$107 | -$224 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21 | -$88 | -$107 | -$224 |
| % Margin | -8.4% | -40.4% | -82.5% | -213% |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | 87.3% | 50% | 50% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 1,653,405 | 1,653,405 | 540,495 | 523,014 |
| Weighted Avg Shares Out Dil | 1,653,405 | 1,653,405 | 540,495 | 523,014 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $17 | $32 | $96 | $89 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$3 | -$54 | -$10 | -$135 |
| % Margin | -1.1% | -24.9% | -8% | -128.3% |